BHST Stock Price, Chart, Stats & News

BioHarvest Sciences Inc.
Save
BioHarvest Sciences Inc. (BHST) does not currently pay a dividend.
31.54M
Market cap
–
Current P/E
153.85x
Forward P/E
BHST chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 59.21% |
Operating margin | -18.77% |
Pretax margin | -35.88% |
Net margin | -36.33% |
Effective tax rate | -1.26% |
ROA | -33.78% |
ROE | -1198.89% |
D/E | 2.57x |
Interest coverage ratio | -1.10x |
BHST valuation
P/E | – |
P/S | 2.30x |
P/B | 9.73x |
P/CF | -9.41x |
P/FCF | -7.47x |
P/OCF | -9.41x |
PEG | -2.22x |
EV multiple | -14.39x |
About
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.
Similar securities
Based on sector and market capitalization
Report issue





